<DOC>
	<DOCNO>NCT00171522</DOCNO>
	<brief_summary>To determine whether female patient preference tegaserod PEG 3350 relative dosage form , convenience , ease administration taste</brief_summary>
	<brief_title>Preference Tegaserod vs. PEG 3350 Patients With Constipation</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Tegaserod</mesh_term>
	<mesh_term>Polyethylene glycol 3350</mesh_term>
	<criteria>Females age 18 64 year age Patients constipation define Rome II criterion Patients previously treat tegaserod and/or PEG 3350 Evidence cathartic colon history laxative abuse laxative dependence History fecal impaction necessitate surgical intervention Patients clinically significant abnormal TSH level screen Women pregnant breast feed Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Constipation</keyword>
	<keyword>Tegaserod</keyword>
	<keyword>Polyethylene Glycol 3350</keyword>
	<keyword>PEG</keyword>
</DOC>